RecruitingPhase 4NCT04130464

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management

The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial

Sponsor

Ying Liu

Enrollment

120 participants

Start Date

Sep 30, 2019

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative Gynecologic Surgical Procedures Hysterectomy Narcotic Use

Summary

The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Normal Saline Infusion from ON-Q Pump, a drug called Ropivacaine + Ketorolac Infusion from ON-Q Pump, and others for people with gynecologic surgical procedures, hysterectomy, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.